SECOND EXTENSION - GRANTED
granted
on 14 Aug 2024
Last Applicant/ Owned by
18 W Mercer St
Seattle
WA
98119
Serial Number
97374157 filed on 21st Apr 2022
Registration Number
N/A
Correspondent Address
Chelsea E. Carbone
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
OZETTE
Medical device for detecting diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; medical device, namely, medical device for disease and disorder diagnosis, monitoring of biological material and cell populations, and medical treatment device in the nature of medical devices for the interrogation of biological samples; Read More
Classification Information
Class [010]
Medical Instrument Products
Medical device for detecting diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; medical device, namely, medical device for disease and disorder diagnosis, monitoring of biological material and cell populations, and medical treatment device in the nature of medical devices for the interrogation of biological samples; medical devices for detection and treatment of infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; apparatus for blood analysis; apparatus for taking blood samples; blood collection kit comprised of medical tubes and vials, tube and vial holders, and transportation device and blood testing apparatus; medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of infectious disease, oncology, autoimmunity, cardiovascular, and neurological disorders; laboratory apparatus, namely, diagnostic apparatus for the interrogation of biological samples featuring artificial intelligence (AI) and machine learning recorded software for medical diagnosis, monitoring, and treatment of diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; laboratory apparatus, namely, diagnostic apparatus for the interrogation of biological samples featuring artificial intelligence (AI) and machine learning recorded software for monitoring the immune system for the purposes of identifying, prescribing, and monitoring medications; laboratory apparatus and instruments in the nature of medical devices and diagnostic apparatus for the interrogation of biological samples for diagnosing diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [009]
Computer & Software Products & Electrical & Scientific Products
Downloadable computer software using artificial intelligence (AI) and machine learning for analysis of immune data for the purposes of medical research, diagnosis, and treatment; downloadable computer software using artificial intelligence (AI) and machine learning for analysis of immune data for the purposes of identifying, prescribing, and monitoring medications; downloadable computer software using artificial intelligence (AI) and machine learning for diagnosing, monitoring, and treating diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; software as a Medical Device (SaMD), downloadable, for analyzing the immune system for the purposes of medical diagnosis and treatment; software as a Medical Device (SaMD), downloadable, for analyzing the immune system for the purposes of identifying, prescribing and monitoring medications; software as a Medical Device (SaMD), downloadable, for diagnosing, monitoring and treating diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; computer hardware; computer hardware with imbedded software for diagnosing, monitoring, and treating diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Medical diagnostic reagents and assays for testing and analyzing blood and other bodily fluids; diagnostic kits comprised of medical diagnostic reagents and assays for testing of blood and other bodily fluids for use in disease and disorder detection, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; pharmaceutical preparations for use in treating infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; drug testing kits comprised of medical diagnostic reagents and assays for testing blood and other bodily fluids; diagnostic reagents for medicinal use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Chemical test kits for diagnosing, monitoring, and treating infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders for laboratory or research use; assays for research purposes; assays for testing blood and other bodily fluids for research purposes; assays and reagents for use in infectious disease, oncology, autoimmunity, cardiovascular, and neurological disorders research
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97374157
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 59646-TM1001
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 14th Aug 2024 | SOU EXTENSION 2 GRANTED |
| 14th Aug 2024 | SOU EXTENSION 2 FILED |
| 14th Aug 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 14th Aug 2024 | SOU TEAS EXTENSION RECEIVED |
| 23rd Mar 2024 | CORRECTED NOA E-MAILED |
| 23rd Mar 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 22nd Mar 2024 | DIVISIONAL PROCESSING COMPLETE |
| 22nd Mar 2024 | SOU EXTENSION 1 GRANTED |
| 29th Feb 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 06th Feb 2024 | TEAS REQUEST TO DIVIDE RECEIVED |